-
.
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
related articles
$17
OFF DEAL50%
OFF DEALGET DEAL181 Used Today
$20
OFF DEALGET DEAL200 Used Today
when hard rains fall, the media are there with an umbrella to hold over organized society�s head. to walk away in the middle of a downpour would leave the status quo unprotected. .